In-vitro Toxicology Testing Market Size Worth $51.1 Billion By 2028: Grand View Research, Inc.

SAN FRANCISCO, Aug. 16, 2021 /PRNewswire/ -- The global in-vitro toxicology testing market size is expected to reach USD 51.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.7% from 2021 to 2028. In recent times, the validation and acceptance of in-vitro and alternative testing methods by regulatory agencies are increasing at lucrative pace. Also, ongoing technological advancements to replace the use of animals for toxicology testing purposes have spurred the use of in vitro testing models, in turn, driving the market.

Key Insights & Findings:

• Growing application of 3D-spheroid-cultures, particularly for nanoparticle toxicity testing, resulted in the dominance of the cell culture technology segment in 2020
• Omics technology is anticipated to register lucrative growth over the forecast period as RNA sequencing and shotgun proteomics are increasingly used in research settings
• The cosmetics industry is expected to be the fastest-growing segment in the near future, creating new avenues for the expansion of HTTs across the globe
• The cellular assays segment dominated the market in 2020 owing to advancements in cell-based technologies, including label-free detection and high-content screening
• The potential of cell imaging technologies is combined with high-content cell screening assays and high-throughput assays for the development of multi-parameter assays
• Systemic toxicology emerged as the leading application segment in 2020 as it plays a key role in risk assessment during drug development procedures
• For instance, toxicity testing of systemic immunosuppressive drugs and systemic corticosteroids is important during the development of drugs for ocular inflammatory disease
• The pharmaceutical industry segment dominated the market in 2020 as toxicological testing is a prerequisite step for drug development
• Stringent government regulations regarding animal usage for toxicity analysis in North America have led to an increased adoption rate of in-vitro models
• In Asia Pacific, the market is anticipated to witness the fastest growth rate over the forecast period
• This is due to increasing initiatives by public agencies to encourage acceptance of non-animal test models
• The key participants are involved in collaborations with bioinformatics research firms in order to develop novel in-silico algorithms for computational estimation of toxicity of pharmaceutical and chemical products
• Moreover, these market entities are also focusing on entering untapped regions in order to maintain their share in market revenue

Read 151 page research report, "In-vitro Toxicology Testing Market Size, Share & Trends Analysis Report By Technology (Cell Culture, High Throughput), By Method, By Application, By End-use (Diagnostics, Chemical Industry, Food Industry), By Region, And Segment Forecasts, 2021 - 2028", by Grand View Research

Several governments are taking measures to minimize animal-based test models, forming conducive government policies, and providing funds to support in-vitro models. These factors are expected to create ample growth opportunities for the market. For instance, in November 2019, the U.S. National Institute for Environmental Health Sciences planned to provide funds to small companies for the development of engineered 3D culture or organotypic culture models (OCM) in-vitro systems.

With advancements in high throughput screening, biological screening, and chemical synthesis, the number of publicly available databases containing data related to toxicity; absorption, distribution, metabolism, and excretion (ADME); pharmacovigilance; and drug screening has expanded rapidly. This has enabled scientists to access vast information for toxicity profiling, thereby spurring revenue generation in this market. Several companies offer HTT-based in vitro toxicology analysis, e.g., Solidus Bioscience's MetaChip Technology, which provides a solution for in vitro toxicology analysis using HTT.

Grand View Research has segmented the global in-vitro toxicology testing market on the basis of end-use, technology, method, application, and region:

• In-vitro Toxicology Testing End-use Outlook, (Revenue, USD Million, 2018 - 2028)
• Pharmaceutical Industry
• Cosmetics & Household Products
• Academic Institutes and Research Laboratories
• Diagnostics
• Chemical Industry
• Food Industry
• In-vitro Toxicology Testing Technology Outlook (Revenue, USD Million, 2018 - 2028)
• Cell Culture Technology
• High Throughput Technology
• Molecular Imaging
• OMICS Technology
• In-vitro Toxicology Testing Application Outlook, (Revenue, USD Million, 2018 - 2028)
• Systemic Toxicology
• Dermal Toxicity
• Endocrine Disruption
• Occular Toxicity
• Others
• In-vitro Toxicology Testing Method Outlook (Revenue, USD Million, 2018 - 2028)
• Cellular Assay
• Live Cells
• High Throughput / High Content Screening
• Molecular Imaging
• Confocal Microscopy
• Others
• Others
• Fixed Cells
• Biochemical Assay
• In-Silico
• Ex-vivo
• In-vitro Toxicology Testing Regional Outlook (Revenue, USD Million, 2018 - 2028)
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Middle East Africa (MEA)
• South Africa

List of Key Players of In-vitro Toxicology Testing Market

• Merck KGaA
• Charles River
• Bio-Rad Laboratories, Inc.
• Abbott
• Thermo Fisher Scientific Inc.
• Catalent, Inc.
• GE Healthcare
• Quest Diagnostics Incorporated
• Eurofins Scientific
• Laboratory Corporation of America Holdings
• Evotec
• Creative Bioarray
• Gentronix
• BioIVT
• SGS SA
• Agilent Technologies.

Check out more studies related to In-Vitro procedures and devices, conducted by Grand View Research:

• In Vitro Fertilization Market – Global in vitro fertilization market size was valued at USD 14.2 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2021 to 2028. Key factors that are driving the market growth include rising reprotourism and the increasing cases of male and female infertility.
• In Vitro Diagnostics Market – Global in vitro diagnostics market size was valued at USD 83.4 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.5% from 2021 to 2027. The growth can be attributed to the increasing adoption of in vitro diagnostics (IVD) owing to a rise in testing due to the pandemic.
• In-vitro Fertilization Microscopes Market – Global in-vitro fertilization microscopes market size was valued at USD 80.8 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 8.43% from 2020 to 2027. In-vitro fertilization (IVF) microscopes are used for various procedures, such as semen analysis, oocyte preparation, in-vitro fertilization, and the overall analysis of the embryo.

Browse through Grand View Research's coverage of the Global Biotechnology Industry.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter 

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg